FUJIFILM Diosynth Biotechnologies vs Richter BioLogics: CDMO Comparison

How does FUJIFILM Diosynth Biotechnologies compare to Richter BioLogics?

As of Nov 2026, FUJIFILM Diosynth Biotechnologies: no FDA inspections on file, 35 EMA/MHRA GMP certificates. Signal Score 86.7. Richter BioLogics: no FDA inspections on file, 9 EMA/MHRA GMP certificates. Signal Score 82.9. Counts are the established FDA, EMA and MHRA records on each profile. CDMOs cannot pay to change a score.

Side-by-side comparison of FUJIFILM Diosynth Biotechnologies and Richter BioLogics on independent FDA inspections, EMA and MHRA GMP certificates, clinical-program activity, and CDMO Signal Score. Data sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.

Research Triangle, NC · Holly Springs, NC · Hillerod, DK
Signal Score
87/100
Quality (FDA + GMP)
100/100
FDA inspections
0
FDA warning letters
0
EMA GMP certificates (active)
29
MHRA GMP certificates (compliant)
6
Clinical programs (matched)
0
Capacity
Expanding
Modalities
AAV, mRNA/LNP, Biologics, mRNA, Microbial Fermentation, Recombinant Protein
Hamburg, Germany
Signal Score
83/100
Quality (FDA + GMP)
100/100
FDA inspections
0
FDA warning letters
0
EMA GMP certificates (active)
9
MHRA GMP certificates (compliant)
0
Clinical programs (matched)
0
Capacity
—
Modalities
Plasmid DNA, Recombinant Proteins, VHH/Nanobodies, Bacterial Vaccines, Biologics, Microbial Fermentation

Key differences

  • FUJIFILM Diosynth Biotechnologies has materially broader EMA GMP coverage (29 active certificates vs 9) — stronger EU footprint.
  • FUJIFILM Diosynth Biotechnologies maintains 6 MHRA / UK GMP certificates; Richter BioLogics does not.

Across the cross-modality scorecard, FUJIFILM Diosynth Biotechnologies carries the higher composite Signal Score — but the right choice depends on the specific modality, phase, and geography of the program.

Frequently asked: FUJIFILM Diosynth Biotechnologies vs Richter BioLogics

How does FUJIFILM Diosynth Biotechnologies compare to Richter BioLogics?

On CDMO Signal's composite Signal Score, FUJIFILM Diosynth Biotechnologies is 87/100 and Richter BioLogics is 83/100; European coverage is 35 active EMA+MHRA certificates for FUJIFILM Diosynth Biotechnologies vs 9 for Richter BioLogics. Both are tracked in the CDMO Signal directory. The scorecard above breaks down every metric side by side — use it alongside each CDMO's individual profile for the full regulatory and clinical footprint.

How do FUJIFILM Diosynth Biotechnologies and Richter BioLogics compare on European GMP coverage?

FUJIFILM Diosynth Biotechnologies holds 29 active EMA GMP certificates and 6 MHRA / UK certificates. Richter BioLogics holds 9 active EMA GMP certificates and 0 MHRA / UK certificates. Use these counts as a proxy for the breadth of each CDMO's European regulatory footprint.

What does the Signal Score gap mean in practice?

FUJIFILM Diosynth Biotechnologies carries a Signal Score of 87/100 and Richter BioLogics carries 83/100 — essentially tied for FUJIFILM Diosynth Biotechnologies. The Signal Score combines quality (FDA inspections + EMA/MHRA GMP), operational performance, financial stability, and capacity intelligence. CDMOs cannot pay to influence their score.

Evaluating FUJIFILM Diosynth Biotechnologies and Richter BioLogics for a program?

Use the free AI matchmaker to weigh both against your specific requirements — capacity, modality, regulatory record, geography — and surface other qualified options.

Find & compare CDMOs →
Sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.